BaroFold Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BaroFold Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011815
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BaroFold Inc (BaroFold) is a biotechnology company that provides protein refolding services. The company offers services such as research study services, optimization study services, and process implementation services. Its optimization study services include confirm analytical services, rescreen refold parameter services, statistical experimental design, scale up studies and evaluate economic services. BaroFold offers process implementation services which include production scale, process transfer to CMO and engineering transfer services. The company offers its services in the areas of protein refolding, aggregate characterization, formulation studies, and microbial expressions. BaroFold is headquartered in Aurora, Colorado, the US.

BaroFold Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BaroFold Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BaroFold Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BaroFold Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BaroFold Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BaroFold Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
BaroFold Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BaroFold Raises US$0.25 Million In Venture Financing 10
Partnerships 11
BaroFold Enters Into Licensing Agreement with Lonza For PreEMT Technology 11
Licensing Agreements 12
BaroFold To Enter Into Licensing Agreement With Boehringer Ingelheim For PreEMT 12
BaroFold Inc – Key Competitors 13
BaroFold Inc – Key Employees 14
BaroFold Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
BaroFold Inc, Pharmaceuticals & Healthcare, Key Facts 2
BaroFold Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BaroFold Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BaroFold Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BaroFold Inc, Deals By Therapy Area, 2011 to YTD 2017 8
BaroFold Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
BaroFold Raises US$0.25 Million In Venture Financing 10
BaroFold Enters Into Licensing Agreement with Lonza For PreEMT Technology 11
BaroFold To Enter Into Licensing Agreement With Boehringer Ingelheim For PreEMT 12
BaroFold Inc, Key Competitors 13
BaroFold Inc, Key Employees 14

★海外企業調査レポート[BaroFold Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Onxeo SA (ONXEO):企業の財務・戦略的SWOT分析
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as beleodaq and asidna among others. It offers drugs for the treatment of liver cancer, and treatment and pr …
  • CGN Power Co Ltd (1816):企業の財務・戦略的SWOT分析
    CGN Power Co Ltd (1816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • DNAtrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …
  • Nh Foods Ltd:企業の戦略・SWOT・財務分析
    Nh Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Nh Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Lombard Odier Private Clients:企業の戦略・SWOT・財務情報
    Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report Summary Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • International Paper Co:企業のM&A・事業提携・投資動向
    International Paper Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's International Paper Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Taubman Centers Inc (TCO):企業の財務・戦略的SWOT分析
    Taubman Centers Inc (TCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Teco Energy Inc:電力:M&Aディール及び事業提携情報
    Summary TECO Energy Inc (TECO), a subsidiary of Emera Inc., is an energy holding company for regulated electricity and gas utilities and other businesses. It generates, transmits, distributes, purchases and sells electricity; and purchases, distributes and sells natural gas through its subsidiaries. …
  • ADMA Biologics Inc (ADMA):企業の財務・戦略的SWOT分析
    ADMA Biologics Inc (ADMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析
    Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • China National Offshore Oil Corp:企業の戦略的SWOT分析
    China National Offshore Oil Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Teco Energy Inc:企業の戦略的SWOT分析
    Teco Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Eagle Pharmaceuticals Inc (EGRX):企業の財務・戦略的SWOT分析
    Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Crowley Maritime Corp:企業の戦略的SWOT分析
    Crowley Maritime Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PT. Matahari Putra Prima Tbk (MPPA):企業の財務・戦略的SWOT分析
    PT. Matahari Putra Prima Tbk (MPPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • APIM Therapeutics AS-製薬・医療分野:企業M&A・提携分析
    Summary APIM Therapeutics AS (APIM) is a drug development company that offers novel anti-cancer therapies. The company offers development of peptide compounds such as mitomycin-c, cisplatin, melphatan, ATX compounds, cytarabine, cisplatin, docetaxel and temozolomide. Its compounds are used in indica …
  • Recurrent Energy LLC:電力:M&Aディール及び事業提携情報
    Summary Recurrent Energy LLC (Recurrent Energy), a subsidiary of Canadian Solar Inc. is a mainstream clean energy company that operates a portfolio of solar energy projects and generates electricity. The company develops and operates a portfolio of utility scale power projects. It has more than 4 GW …
  • Baloise Holding Ltd:企業の戦略・SWOT・財務情報
    Baloise Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary Baloise Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eolus Vind AB (EOLU B):企業の財務・戦略的SWOT分析
    Summary Eolus Vind AB (Eolus Vind) is a wind farm developer that offers construction, development, and operation of green field projects and wind power plants. The company provides services such as consultancy services, administration, financing, development, and management of wind farms. It also of …
  • Reply S.p.A. (REY):企業の財務・戦略的SWOT分析
    Reply S.p.A. (REY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆